Releases

Media coverage

Newsletter

Subscribe to our newsletter

Archive


Apr 3, 2013

Lytix Biopharma'’s infection drug candidate has the potential to treat and prevent skin infections

The following article in Norwegian deals with antibiotic resistance, click to read in Norwegian